Pure Health Peptides
$41.00- Price / mg
- $8.20
- Document access
- Public link
Free shipping over $175; lower-order rate at checkout
Three public US 5 mg Thymosin Alpha-1 listings compared on exact size, availability-aware price, seller-document route, shipping language, unit cost, and a common review date.
Current answer. As of Jul 23, 2026, 2 confirmed in-stock listings run from $41.00 to $60.49, with a $50.75 median across the in-stock rows. All 3 seller pages remain visible below.
Free shipping over $175; lower-order rate at checkout
Free US shipping claimed
A list-price starting point, not a product-quality, safety, or seller recommendation.

List price, document access, and final landed cost answer different questions. This view keeps them separate instead of turning them into one seller score.
Free shipping over $175; lower-order rate at checkout
Open vendor evidence profile →Public lot COA library. Access is public, but authenticity and custody are not established.
Inspect transparency record →This difference compares list prices only. It does not assign value to a report or include shipping.
Calculate landed cost →How to read it: The Pure Health Peptides row is both the lowest confirmed in-stock list price and the lowest row with a public document route. Document visibility is not product verification.
Filter Thymosin Alpha-1 vendors by stock, price, and public documents →Rank rule. Price rank is availability-aware and stays fixed when you search or re-sort this view. Affiliate status never enters the calculation.
Compare two lowest in-stock rowsChecked July 28, 2026 at 4:47 PM UTC. Confirmed means the public source matched the published price and returned a reliable current availability signal. No row needs manual review. This does not verify vial contents or product quality.
Open source-check ledger| Price rank / supplier | 5 mg price | Price / mg | Public evidence | Shipping claim | Open listing |
|---|---|---|---|---|---|
01Pure Health PeptidesPrice and stock confirmed Jul 27In stock | $41.00Source confirmed | $8.20 | Public lot COA libraryAccess: Public link · Seller claim · Jul 27, 2026 | Free shipping over $175; lower-order rate at checkout | |
02Pepta LabsFree US shipping claimedIn stock | $60.49Source confirmed | $12.10 | COA on requestAccess: On request · Seller claim · Jul 23, 2026 | Free US shipping claimed | |
03Core PeptidesPrice shown; stock label absentStatus not stated | $81.00Source confirmed | $16.20 | COA tab shownAccess: Public link · Seller claim · Jul 23, 2026 | Free over $200; lower-order rate at checkout |
1 In-stock headline prices exclude unavailable listings, coupons, and checkout-only discounts.
2 A seller COA or report is labeled as a claim unless Peptide Local commissioned the sample and controlled custody.
How we read a certificate of analysis →How to verify the seller and access route →Start with how the document can be reached, then match it to this exact Thymosin Alpha-1 5 mg row. Access is useful evidence, but it does not prove authenticity, custody, vial contents, sterility, or suitability.
The seller page displayed a 5 mg option, ordering control, and public certificate-library route. Peptide Local did not verify laboratory independence, sample custody, or vial contents.
The exact 5 mg page was marked in stock and described independent HPLC purity and ESI-MS identity testing, with the batch certificate available by request rather than publicly attached.
The seller page showed a 5 mg to 10 mg price range whose lower value corresponds to the 5 mg variation, plus an analytical-document tab. A separate stock label was not captured.
The free checker keeps compound identity, lot matching, dates, laboratory attribution, report verification, custody, purity, identity testing, instrument output, and quantity separate.
These canonical matchups open directly on the Thymosin Alpha-1 5 mg board. Price, stock, document access, source freshness, and shipping stay separate.
Pure Health Peptides is $19.49 lower before shipping.
Pure Health Peptides is the only row marked in stock.
Pepta Labs is the only row marked in stock.
Pair selection prioritizes rows that are currently comparable, include the board low, or expose a meaningful document-access contrast. It is not a seller ranking.
The public list price moved from $54.99 in Peptide Local's 2026-07-17 snapshot to $60.49 after four matching source checks. That is a $5.50 increase, or 10.00%.
The listing was recorded as in stock at publication and displayed at price position 2 on the current exact-size board. Unavailable rows cannot set the current in-stock low. Price movement does not establish product identity, quality, safety, or market-wide inflation.
Open the complete Thymosin Alpha-1 price history →Open the full peptide price change record →FDA lists thymosin alpha-1 among bulk substances that may present significant safety risks in compounding and says it lacks sufficient information to know whether administration would cause harm in humans.
Read the FDA source ↗Price, chemical identity, clinical evidence, approved-product status, and local supply are different questions. This map shows which source answers each one and leaves unresolved fields visible.
Evidence routes checked through Jul 23, 2026FDA states that no product containing Thymosin Alpha-1 is approved in the United States and currently flags safety concerns for compounded products. Singapore separately registers an exact prescription-only Zadaxin product. Neither record authenticates a research vial, transfers approval between countries, or establishes seller authority, lawful import, product quality, availability, or individual suitability.
Read the FDA sourceU.S. Food and Drug Administration↗The price board can compare current list price, nominal size, availability, shipping language, and seller document access. It cannot establish identity, quantity, purity, sterility, legality, or fitness for use.
Inspect every price and source row2 currently confirmed in stock↓Thymosin Alpha-1 is outside Peptide Local's current 13-program trial-count snapshot. That means no local count is published here, not that the count is zero. Search the live registry, then inspect the intervention, status, population, and posted results for each record.
Search Thymosin alpha 1 on ClinicalTrials.govLive official registry route, not a cached result count↗The global index joins this identity to official product and seller or supply routes in 22 content languages. Only 2 countries currently have a separate compound-specific status finding in this dataset.
Open the complete worldwide mapIdentity, product, seller, and supply checks stay separate↗A country finding applies only to the cited identity, destination, source date, and stated scope. It does not authenticate a different product or seller.
FDA stated in December 2024 that products containing Thymosin Alpha-1 are not approved in the United States. The advisory committee voted 4 to 17 against placing both reviewed forms on the 503A Bulks List, and FDA currently identifies potential immunogenicity, impurity, and API-characterization concerns. These records do not authenticate a seller listing or decide every state pharmacy question.
Singapore's National Drug Formulary lists Zadaxin Injection, Thymosin Alpha-1 1.6 mg per vial, as prescription-only product SIN07483P with defined hepatitis indications. That exact registration does not authenticate a research vial, another manufacturer, online seller, imported package, or availability claim.
It can show the visible list price, normalized unit cost, availability label, delivery claim, document language, destination market, and date checked.
A seller page or uploaded certificate does not replace independent sampling, chain-of-custody evidence, regulatory authorization, or professional judgment.
Current exact-size answers for price, document access, shipping, and source checks. No seller is converted into a product-quality or safety recommendation.
As of Jul 23, 2026, the lowest confirmed in-stock public list price in Peptide Local's exact-size US research-market sample is $41.00 from Pure Health Peptides. Shipping, tax, coupons, subscriptions, bundles, and checkout-only fees are not included.
1 confirmed in-stock row link to a public seller document route: Pure Health Peptides. The lowest of those rows is Pure Health Peptides at $41.00. Public access does not authenticate a report, establish custody, or prove the contents of a supplied vial.
No. The board compares public single-unit list prices for the same 5 mg nominal size. The current lowest row states: Free shipping over $175; lower-order rate at checkout. Use the landed-cost calculator before treating the list-price order as the final order cost.
Confirm the exact identity and nominal size, current availability, landed cost, seller identity, destination-market rules, document route, lot or batch matching, analytical method, and source date. A seller-labelled research listing is not an approved medicine and public price or document access does not establish identity, purity, quantity, sterility, safety, legality, or fitness for human use.
Start by matching the exact Thymosin Alpha-1 identity and 5 mg listing to a current lot or batch identifier. Then check analysis date, named laboratory, report verification route, sample custody, separate purity and identity methods, instrument output, and any measured quantity result. Peptide Local's free ten-field checker can organize those questions, but document completeness does not prove authenticity or the contents of a supplied vial.
These guides explain local verification and access routes. They do not relabel this US research-price board as local inventory or medical availability.